Your browser doesn't support javascript.
loading
Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility.
Pinto, Emilia M; Fridman, Cintia; Figueiredo, Bonald C; Salvador, Hector; Teixeira, Manuel R; Pinto, Carla; Pinheiro, Manuela; Kratz, Christian P; Lavarino, Cinzia; Legal, Edith A M F; Le, Anh; Kelly, Gregory; Koeppe, Erika; Stoffel, Elena M; Breen, Kelsey; Hahner, Stefanie; Heinze, Britta; Techavichit, Piti; Krause, Amanda; Ogata, Tsutomu; Fujisawa, Yasuko; Walsh, Michael F; Rana, Huma Q; Maxwell, Kara N; Garber, Judy E; Rodriguez-Galindo, Carlos; Ribeiro, Raul C; Zambetti, Gerard P.
Afiliación
  • Pinto EM; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: emilia.pinto@stjude.org.
  • Fridman C; Departamento de Medicina Legal, Bioética, Medicina do Trabalho e Medicina Física e Reabilitação, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Figueiredo BC; Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, Paraná, Brazil.
  • Salvador H; Pediatric Oncology Department, Sant Joan de Deu Hospital, Barcelona, Spain.
  • Teixeira MR; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Porto, Portugal; Department of Laboratory Genetics, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center and School of Medicine and Biomedical Sciences (ICBAS), Univer
  • Pinto C; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Porto, Portugal.
  • Pinheiro M; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Porto, Portugal.
  • Kratz CP; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • Lavarino C; Pediatric Oncology Department, Sant Joan de Deu Hospital, Barcelona, Spain.
  • Legal EAMF; Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, Paraná, Brazil.
  • Le A; Department of Medicine-Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Kelly G; Department of Medicine-Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Koeppe E; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Stoffel EM; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Breen K; Department of Pediatrics and Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hahner S; Department of Medicine I, Division of Endocrinology and Diabetology, University Hospital Wuerzburg, Wuerzburg, Germany.
  • Heinze B; Department of Medicine I, Division of Endocrinology and Diabetology, University Hospital Wuerzburg, Wuerzburg, Germany.
  • Techavichit P; Integrative and Innovative Hematology/Oncology Research Unit, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Krause A; Division of Human Genetics, National Health Laboratory Service (NHLS) and Faculty of Health Sciences, School of Pathology, The University of the Witwatersrand, Johannesburg, South Africa.
  • Ogata T; Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Fujisawa Y; Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Walsh MF; Department of Pediatrics and Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Rana HQ; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Maxwell KN; Department of Medicine-Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Garber JE; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Rodriguez-Galindo C; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Ribeiro RC; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Zambetti GP; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: Gerard.zambetti@stjude.org.
HGG Adv ; 5(1): 100244, 2024 Jan 11.
Article en En | MEDLINE | ID: mdl-37794678
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Neoplasias Límite: Female / Humans / Male Idioma: En Revista: HGG Adv Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Neoplasias Límite: Female / Humans / Male Idioma: En Revista: HGG Adv Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos